Seroepidemiology of human herpesvirus 8 among young men who have sex with men

Sexually Transmitted Diseases

Volumn 28, Issue 3, 2001, Pages 176-183

  Diamond, Catherine ^a   Thiede, Hanne ^b   Perdue, Thomas ^b   MacKellar, Duncan ^c   Valleroy, Linda A ^c   Corey, Lawrence ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC PROCEDURE; HERPES; HUMAN; HUMAN HERPESVIRUS 8; INTRAVENOUS DRUG ABUSE; MALE; RISK FACTOR; SEROEPIDEMIOLOGY; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

EID: 0035119685     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200103000-00010     Document Type: Article

References (46)

1. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
2. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection
3. Epidemiologic clues to the etiology of Kaposi's sarcoma
4. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon
5. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents
6. Absence of detectable human herpes virus eight in the semen of HIV-infected men
7. Human herpesvirus 8 in semen and prostate
8. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of human immunodeficiency virus-infected men: Clinical and immunologic correlates
9. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma
10. Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus
11. Human herpesvirus 8 detection in nasal secretions and saliva
12. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
13. KSHV antibodies among Americans. Italians, and Ugandans with and without Kaposi's sarcoma
14. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
15. The Young Men's Survey, methods for estimating HIV seroprevalence and risk factors among young men who have sex with men
16. Determination of the etiology of seroreversals in HIV testing by antibody fingerprinting
17. Individual-specific antibody profiles as a means of newborn infant identification
18. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
19. Establishment and characteristics of an Epstein-Barr Virus (EBV)-negative B-lymphoma line (BJA-B) from an exceptional EBV-genome-negative African Burkitt lymphoma
20. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen
21. Detection of Kaposi's sarcoma herpesvirus DNA in semen of homosexual men with Kaposi's sarcoma
22. Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors
23. Localization of human herpes virus eight (HHV-8) and HHV-8 gene expression in prostate tissue of men with Kaposi's sarcoma
24. Serologic evidence of human herpesvirus 8 transmission by homosexual not heterosexual sex
25. Human herpesvirus 8: Seroepidemiology among women and detection in the genital tract of seropositive women
26. Sexual transmission and the natural history of human herpesvirus 8 infection
27. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: Rates, risk factors, and relationship to Kaposi's sarcoma
28. Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners
29. Interassay correlation of human herpesvirus 8 serologic tests: HHV-8 Interlaboratory Collaborative Group
30. Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements
31. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients
32. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma
33. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-I infection
34. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide
35. Patterns of sexual behavior and condom use in a cohort of homosexual men
36. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons
37. Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS
38. Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids
39. Injecting and sexual risk-taking behavior among regular amphetamine users
40. Sexual risk for HIV transmission among gay/bisexual men in substance use treatment
41. Incidence of HIV and sexually transmitted diseases in a cohort of HIV-negative men who have sex with men
42. Sexual factors associated with cytomegalovirus seropositivity in human immunodeficiency virus-infected men
43. HIV prevalence and associated risks in young men who have sex with men